🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to explore the safety and tolerability of an investi...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01446926
Treatments Being Tested
This phase 2 clinical trial will investigate an optimal dose, dosing regime...
Status
Active Not Recruiting
Location
Benchmark Research
Start Date
2025-03-10
Trial ID
NCT06899802
Treatments Being Tested
A total of 96 subjects will be recruited into 5 groups. Each subject will r...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-09
Trial ID
NCT02864628
Treatments Being Tested
Phase 3 randomized, double blind study comparing recombinant MVA-BN-RSV vac...
Status
Terminated
Location
North Alabama Research Center, LLC
Start Date
2022-04-19
Trial ID
NCT05238025
Treatments Being Tested
The purpose of this study is to determine the safety, efficacy and pharmaco...
Status
Completed
Location
Multiple Locations
Start Date
2012-04
Trial ID
NCT01579565
The purpose of this study is to evaluate the safety, tolerability of differ...
Status
Completed
Location
Multiple Locations
Start Date
2015-11-12
Trial ID
NCT02546960
Phase I/II, randomized, double-blind, placebo-controlled, safety, immunogen...
Status
Completed
Location
PHRU, Chris Hani Baragwanath Hospital
Start Date
2013-07-01
Trial ID
NCT01861730
This study is a Phase I, first-in-human (FIH), double-blind, placebo- and O...
Status
Completed
Location
University of the Sunshine Coast Clinical Trial Centre
Start Date
2022-11-03
Trial ID
NCT05604690
Treatments Being Tested
The present trial is a phase I first in human, double blind, parallel and p...
Status
Completed
Location
NIHR/Wellcome Trust Imperial Clinical Research Facility, Hammersmith Hospital
Start Date
2016-07
Trial ID
NCT02787109
Treatments Being Tested
This study is designed to evaluate the safety, tolerability, and immunogeni...
Status
Completed
Location
Multiple Locations
Start Date
2010-02
Trial ID
NCT01444339